Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000190

Chairperson & CEO sold 9,500 shares at an average $587.74 ($5,583,501)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

16 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-16 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-11-16 Sale : show line 2 in the form 10b5-1 −110 $580.25 $63,828 333,833 I
2026-11-16 Sale : show line 3 in the form 10b5-1 −170 $581.25 $98,813 333,663 I
2026-11-16 Sale : show line 4 in the form 10b5-1 −280 $582.18 $163,010 333,383 I
2026-11-16 Sale : show line 5 in the form 10b5-1 −240 $583.61 $140,066 333,143 I
2026-11-16 Sale : show line 6 in the form 10b5-1 −640 $584.54 $374,104 332,503 I
2026-11-16 Sale : show line 7 in the form 10b5-1 −1,382 $585.83 $809,621 331,121 I
2026-11-16 Sale : show line 8 in the form 10b5-1 −2,108 $586.72 $1,236,796 329,013 I
Open-market sales · 9,500 sh · avg $587.74 · $5,583,501

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2026-11-16 Exercise or conversion : show line 17 in the form 10b5-1 Stock Option −9,500 $117.76 2027-03-15 9,500 14,910 I
Loading xslF345X06/primarydocument.xml…